Cleared Traditional

K821945 - CARBAMAZEPINE FLOURESCENT IMMUNOASSAY
(FDA 510(k) Clearance)

Jul 1982
Decision
17d
Days
Class 2
Risk

K821945 is an FDA 510(k) clearance for the CARBAMAZEPINE FLOURESCENT IMMUNOASSAY. This device is classified as a Enzyme Immunoassay, Carbamazepine (Class II - Special Controls, product code KLT).

Submitted by American Diagnostic Corp. (Mchenry, US). The FDA issued a Cleared decision on July 16, 1982, 17 days after receiving the submission on June 29, 1982.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3645.

Submission Details

510(k) Number K821945 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 29, 1982
Decision Date July 16, 1982
Days to Decision 17 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary

Device Classification

Product Code KLT — Enzyme Immunoassay, Carbamazepine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3645

Similar Devices — KLT Enzyme Immunoassay, Carbamazepine

All 55
Carbamazepine Gen 4
K151578 · Roche Diagnostics Operations (Rdo) · Oct 2015
ABBOTT CARBAMAZEPINE ASSAY
K123518 · Microgenics Corporation · Jun 2013
ARCHITECT ICARBAMAZEPINE ICARBAMAZEPINE REAGENTS; ARCHITECT ICARBAMAZEPINE CALIBRATORS
K103627 · Abbott Laboratories · Oct 2011
CARBAMAZEPINE, VALPROIC ACID, TDM CALIBRATION SET B AND ABTROL, NORTROL CONTROLS
K063131 · Thermo Electron OY · Oct 2007
ADVIA IMS CARBAMAZEPINE METHOD
K042808 · Bayer Healthcare, LLC · Feb 2005
ONLINE TDM CARBAMAZEPINE
K031902 · Roche Diagnostics Corp. · Sep 2003